September 15, 2005

Schering-Plough Animal Health names Haacke Marketing Manager, Global Aquaculture

Schering-Plough Animal Health Corporation has appointed Chris Haacke to the position of Marketing Manager, Global Aquaculture.

Based at Schering-Plough Aquaculture's European office in Saffron Walden, England, Haacke would work with the company's aquaculture business managers worldwide to develop marketing strategies, brand positioning and new markets for the company's AQUAVAC™ line of vaccines.

Haacke would be involved in all of the aspects of marketing management for Schering Plough Animal Health's growing aquaculture business. He would be responsible for developing the marketing programmes for the health products being introduced across Europe under the mutual recognition regulatory processes.

Prior to joining Schering-Plough Animal Health, Haacke spent over nine years in aquaculture sales and marketing, four of which with Eurosea developing international sales for farmed salmon. He spent five years as sales and Marketing Director at Pan Fish, one of the leading global salmon farming companies, where he developed the quality aspects of the brand to achieve rapid sales growth in European and Japanese markets.

Haacke holds a BSc Joint Honours degree in Geography and Computer Science from Keele University, UK, and is currently pursuing his Master's of Business Administration at Surrey University, School of Management, also in the UK.

For more information about Schering-Plough Animal Health and its expanding line of products for aquaculture, including AQUAFLOR® (florfenicol) antibiotic and SLICE® (emamectin benzoate) parasiticide and the AQUAVAC line of vaccines, go to www.spaquaculture.com or call +1-908-629-3349 (US) or +44-1799-528167 (UK).

Schering-Plough Animal Health Corporation is the worldwide animal health business of Schering-Plough Corporation (NYSE: SGP) of Kenilworth, New Jersey, US.  Schering-Plough is a global science-based health care company with leading prescription, consumer and animal health products.  Through internal research and collaborations with partners, Schering-Plough discovers, develops, manufactures and markets advanced drug therapies to meet important medical needs.  Schering-Plough's vision is to earn the trust of physicians, patients and customers served by its more than 30,000 people around the world.

AQUAVAC is a trademark and AQUAFLOR and SLICE are registered trademarks of Schering-Plough Veterinary Corporation.